Details of the Drug
General Information of Drug (ID: DMCLVOZ)
Drug Name |
Aminocarbonyl dihydrogen phosphate
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
carbamoylphosphate; CARBAMYL PHOSPHATE; Carbamoyl phosphate; phosphono carbamate; 590-55-6; aminocarbonyl dihydrogen phosphate; monocarbamoyl phosphate; PHOSPHORIC ACID MONO(FORMAMIDE)ESTER; carbamoyl dihydrogen phosphate; CHEMBL369105; carbamic phosphoric monoanhydride; CHEBI:17672; carbamoyl-P; carbamyl-phosphate; carbamoyl-phosphate; carbamoyl phosphoric acid; AC1L18VP; SCHEMBL50374; Carbamic acid, monoanhydride with phosphoric acid; (carbamoyloxy)phosphonic acid; AC1Q68Q7; ZINC8383183; BDBM50162819; AKOS006341689; carbamic aci
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 141.02 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -2.1 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 3 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||